Proteon logo     Print Page | Close Window

SEC Filings

S-1
PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document
 

 

(10) trading day period ending five (5) trading days prior to the date of determination of fair market value;

 

B =                                                     The cash purchase price per share that the Purchaser is required to pay pursuant to this Agreement in connection with the purchase of the applicable class or series of Shares with respect to which the Net Issue Election is made.

 

Net Issue Election Form” means the Net Issue Election Form attached as Exhibit I hereto.

 

Note Conversion Price” shall have the meaning set forth in Section 1.1(b)(i) hereto.

 

Note Conversion Shares” shall have the meaning set forth in Section 1.1(b)(i) hereto.

 

Noteholder Purchaser” shall have the meaning set forth in Section 1.1(b)(i) hereto.

 

Novartis” means Novartis International Pharmaceutical Limited.

 

Option Agreement” means that certain Option Agreement between the Company and Novartis, dated as of March 27, 2009.

 

Person” means any individual, corporation, partnership, trust, limited liability company, association or other entity.

 

Pharmstandard” means Pharmstandard International S.A., with registered address 65, Boulevard Grande-Duchesse Charlotte L - 1331 Luxembourg.

 

“Preferred Stock” means the Series A Preferred Stock, the Series A-1 Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock and the Series D Preferred Stock.

 

Prism V LP” means Prism Venture Partners V, L.P.

 

Prism V-A LP” means Prism Venture Partners V-A, L.P.

 

Prior Investors’ Rights Agreement” shall have the meaning set forth in Section 1.6.

 

Proposed Budgets” shall have the meaning set forth in Section 5.1(n).

 

Purchaser” shall have the meaning set forth in the Preamble.

 

Restated Certificate” shall have the meaning set forth in Section 1.1(a) hereof.

 

Restricted Period” means the period commencing on the date on which the Company either submits a registration statement on Form S-1 to the United States Securities and Exchange Commission on a confidential basis pursuant to Jumpstart Our Business Startups Act or files a registration statement on Form S-1 with the United States Securities and Exchange Commission pursuant to the Securities Act and ending on the earlier of (i) the third business day

 

13